Trimbow shows promise for COPD patients not helped by other inhalers
Disease control
Completed
This study followed over 1,300 people with moderate to severe COPD whose symptoms were not controlled by standard dual inhalers. Researchers measured how Trimbow, a triple-combination inhaler, affected their quality of life and lung function over six months. The goal was to see i…
Sponsor: Chiesi Hungary Ltd. • Aim: Disease control
Last updated Jun 26, 2026 15:24 UTC